Adv Drug Deliv Rev. 2014 Nov 30;78:28-45. doi: 10.1016/j.addr.2014.10.013.
Antimicrobial peptides (AMPs) which predominantly act via membrane active mechanisms have emerged as an exciting class of antimicrobial agents with tremendous potential to overcome the global epidemic of antibiotics-resistant infections. The first generation of AMPs derived from natural sources as diverse as plants, insects and humans has provided a wealth of compositional and structural information to design novel synthetic AMPs with enhanced antimicrobial potencies and selectivities, reduced cost of production due to shorter sequences and improved stabilities under physiological conditions. In this review, we will first discuss the common strategies employed in the design and optimization of synthetic AMPs, followed by highlighting the various approaches utilized to enhance the therapeutic potentials of designed AMPs under physiological conditions. Lastly, future perspectives on the development of improved AMPs for therapeutic applications will be presented.
抗菌肽(AMPs)主要通过膜活性机制发挥作用,作为一类令人兴奋的抗菌药物,具有巨大的潜力来克服全球抗生素耐药性感染的流行。第一代 AMP 来源于植物、昆虫和人类等多种天然来源,为设计具有增强的抗菌效力和选择性、由于序列较短而降低生产成本以及在生理条件下提高稳定性的新型合成 AMP 提供了丰富的组成和结构信息。在这篇综述中,我们将首先讨论设计和优化合成 AMP 中使用的常见策略,然后重点介绍在生理条件下增强设计 AMP 的治疗潜力所采用的各种方法。最后,将提出对抗菌肽治疗应用的改进的未来展望。